Are Mycobacterium avium subsp paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia?

被引：29
|
作者：
Cossu, Davide [1 ]
Masala, Speranza [1 ]
Cocco, Eleonora [2 ]
Paccagnini, Daniela [1 ]
Frau, Jessica [2 ]
Marrosu, Maria Giovanna [2 ]
Sechi, Leonardo A. [1 ]
机构：
[1] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol Sperimentale & Clin, I-07100 Sassari, Italy
[2] Univ Cagliari, Ctr Sclerosi Multipla, Dipartimento Sci Cardiovasc & Neurol, I-09124 Cagliari, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷 / 08期
关键词：
Mycobacterium avium subsp; paratuberculosis; Epstein Barr virus; multiple sclerosis; Sardinian;
D O I：
10.1177/1352458511433430
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Sardinia acts as an ideal setting for multiple sclerosis (MS) studies because its prevalence of MS is one of the highest worldwide. Several pathogens have been investigated amongst 119 Sardinian MS patients and 117 healthy controls to determine whether they might have a role in triggering MS in genetically predisposed individuals. Mycobacterium avium subsp. paratuberculosis (MAP) and Epstein Barr virus DNA were detected in 27.5% and 17.3%, respectively, of the MS patients. Moreover an extremely high humoral immune response against MAP recombinant protein MAP FprB (homologous to human myelin P0) was observed, whereas no significant results were found against Mycobacterium tuberculosis FprA and Helicobacter pylori HP986 protein.
引用
收藏
页码：1181 / 1184
页数：4
相关论文
共 50 条
  • [31] The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
    Pender, Michael P.
    NEUROSCIENTIST, 2011, 17 (04) : 351 - 367
  • [32] Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis
    Debuysschere, Cyril
    Nekoua, Magloire Pandoua
    Hober, Didier
    MICROORGANISMS, 2023, 11 (05)
  • [33] The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?
    Munch, M
    Riisom, K
    Christensen, T
    Moller-Larsen, A
    Haahr, S
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 97 (03): : 171 - 174
  • [34] Elevated mycobacterium avium subsp. paratuberculosis (MAP) antibody titer in Japanese multiple sclerosis
    Hayashi, Fumie
    Isobe, Noriko
    Cossu, Davide
    Yokoyama, Kazumasa
    Sakoda, Ayako
    Matsushita, Takuya
    Hattori, Nobutaka
    Kira, Jun-ichi
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 360
  • [35] Controversial Role of Epstein-Barr Virus in Multiple Sclerosis
    Fatima, Nazneen
    Toscano, Michael P.
    Hunter, Stephen B.
    Cohen, Cynthia
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2011, 19 (03) : 246 - 252
  • [36] Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials
    Lanz, Tobias, V
    Robinson, William H.
    Ho, Peggy P.
    Steinman, Lawrence
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2023, 12 (02)
  • [37] Multiple sclerosis and Epstein-Barr virus. New developments and perspectives
    Ruprecht, K.
    NERVENARZT, 2008, 79 (04): : 399 - +
  • [38] Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis
    Hon, Gloudina M.
    Hassan, Mogamat S.
    van Rensburg, Susan J.
    Erasmus, Rajiv T.
    Matsha, Tandi E.
    METABOLIC BRAIN DISEASE, 2012, 27 (03) : 311 - 318
  • [39] Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis
    Lindsey, J. W.
    Hatfield, L. M.
    Crawford, M. P.
    Patel, S.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (02) : 153 - 158
  • [40] Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection
    Pender, Michael P.
    AUTOIMMUNITY REVIEWS, 2009, 8 (07) : 563 - 568
12345